---
figid: PMC6752729__nzz101fig1
figlink: /pmc/articles/PMC6752729/figure/fig1/
number: FIGURE 1
caption: Summary of molecular basis on which epigallocatechin-3-gallate (EGCG) prevents
  chronic kidney disease (CKD) and renal fibrosis based on preclinical evidence. The
  anti–oxidative stress properties of EGCG are exerted through its inhibition of mitochondrial
  dysfunction and its induction of antioxidant enzymes via activation of the Nrf2/HO-1
  signaling pathway. For its anti-inflammation property, EGCG inhibits NF-κB signaling
  and inflammasome formation resulting in inhibition of the inflammatory cascade.
  Moreover, EGCG exhibits an anti-EMT property through various signaling pathways,
  including TGF-β1/Smad, β-catenin, and Nrf2 pathways, to prevent fibrotic transdifferentiation
  by the EMT process. Shaded boxes (in light orange) represent molecular events that
  occur in CKD, which can be inhibited or prevented by EGCG. ARE, antioxidant responsive
  element; Cul3, cullin-3; E2, E2 ubiquitin-conjugating enzyme; ECM, extracellular
  matrix; EMT, epithelial mesenchymal transition; GPx, glutathione peroxidase; HO-1,
  heme oxygenase 1; Keap1, Kelch-like ECH-associated protein 1; MDA, malondialdehyde;
  MPO, myeloperoxidase; NLRP3, nucleotide-binding domain, leucine-rich repeat-containing
  family, pyrin domain-containing 3; NQO1, NAD(P)H:quinone oxidoreductase 1; Nrf2,
  nuclear factor erythroid 2-related factor 2; ROS, reactive oxygen species; SOD,
  superoxide dismutase; TGF-β1, transforming growth factor-β1; Ub, ubiquitin; ZO-1,
  zonula occludens-1; α-SMA, α-smooth muscle actin; 8-OHdG, 8-hydroxy-2'-deoxyguanosine.
pmcid: PMC6752729
papertitle: 'Molecular Mechanisms of Epigallocatechin-3-Gallate for Prevention of
  Chronic Kidney Disease and Renal Fibrosis: Preclinical Evidence.'
reftext: Rattiyaporn Kanlaya, et al. Curr Dev Nutr. 2019 Sep;3(9):nzz101.
pmc_ranked_result_index: '76224'
pathway_score: 0.6760255
filename: nzz101fig1.jpg
figtitle: Summary of molecular basis on which epigallocatechin-3-gallate (EGCG) prevents
  chronic kidney disease (CKD) and renal fibrosis based on preclinical evidence
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6752729__nzz101fig1.html
  '@type': Dataset
  description: Summary of molecular basis on which epigallocatechin-3-gallate (EGCG)
    prevents chronic kidney disease (CKD) and renal fibrosis based on preclinical
    evidence. The anti–oxidative stress properties of EGCG are exerted through its
    inhibition of mitochondrial dysfunction and its induction of antioxidant enzymes
    via activation of the Nrf2/HO-1 signaling pathway. For its anti-inflammation property,
    EGCG inhibits NF-κB signaling and inflammasome formation resulting in inhibition
    of the inflammatory cascade. Moreover, EGCG exhibits an anti-EMT property through
    various signaling pathways, including TGF-β1/Smad, β-catenin, and Nrf2 pathways,
    to prevent fibrotic transdifferentiation by the EMT process. Shaded boxes (in
    light orange) represent molecular events that occur in CKD, which can be inhibited
    or prevented by EGCG. ARE, antioxidant responsive element; Cul3, cullin-3; E2,
    E2 ubiquitin-conjugating enzyme; ECM, extracellular matrix; EMT, epithelial mesenchymal
    transition; GPx, glutathione peroxidase; HO-1, heme oxygenase 1; Keap1, Kelch-like
    ECH-associated protein 1; MDA, malondialdehyde; MPO, myeloperoxidase; NLRP3, nucleotide-binding
    domain, leucine-rich repeat-containing family, pyrin domain-containing 3; NQO1,
    NAD(P)H:quinone oxidoreductase 1; Nrf2, nuclear factor erythroid 2-related factor
    2; ROS, reactive oxygen species; SOD, superoxide dismutase; TGF-β1, transforming
    growth factor-β1; Ub, ubiquitin; ZO-1, zonula occludens-1; α-SMA, α-smooth muscle
    actin; 8-OHdG, 8-hydroxy-2'-deoxyguanosine.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GPX6
  - GPX1
  - GPX7
  - HMOX1
  - CDH2
  - NFKB1
  - NLRP3
  - SMAD1
  - SMAD2
  - SMAD3
  - GPX2
  - IL6
  - MPO
  - CTNNB1
  - CUL3
  - CDH1
  - IL18
  - SOD3
  - SOD2
  - SOD1
  - GPX8
  - SMAD7
  - SMAD4
  - SMAD5
  - SMAD6
  - TNF
  - GPX3
  - GPX4
  - GPX5
  - SMAD9
  - TGFB1
  - ATP
  - 8-OHDG
  - MDA
  - H
  - EGCG
  - Mitochondrial dysfunction
genes:
- word: GPx,
  symbol: GPX
  source: bioentities_symbol
  hgnc_symbol: GPX6
  entrez: '257202'
- word: GPx,
  symbol: GPX
  source: bioentities_symbol
  hgnc_symbol: GPX1
  entrez: '2876'
- word: GPx,
  symbol: GPX
  source: bioentities_symbol
  hgnc_symbol: GPX7
  entrez: '2882'
- word: Nrf2/HO-1
  symbol: HO-1
  source: hgnc_alias_symbol
  hgnc_symbol: HMOX1
  entrez: '3162'
- word: N-cadherin,
  symbol: CDH2
  source: hgnc_symbol
  hgnc_symbol: CDH2
  entrez: '1000'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NLRP3)
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: TGF-B1/Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: TGF-B1/Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: TGF-B1/Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: GPx,
  symbol: GPX
  source: bioentities_symbol
  hgnc_symbol: GPX2
  entrez: '2877'
- word: IL-6,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: MPO,
  symbol: MPO
  source: hgnc_symbol
  hgnc_symbol: MPO
  entrez: '4353'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Cul3
  symbol: CUL3
  source: hgnc_symbol
  hgnc_symbol: CUL3
  entrez: '8452'
- word: E-cadherin,
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: (e.g.,IL-18,IL-18,
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: SOD,
  symbol: SOD
  source: bioentities_symbol
  hgnc_symbol: SOD3
  entrez: '6649'
- word: SOD,
  symbol: SOD
  source: bioentities_symbol
  hgnc_symbol: SOD2
  entrez: '6648'
- word: SOD,
  symbol: SOD
  source: bioentities_symbol
  hgnc_symbol: SOD1
  entrez: '6647'
- word: GPx,
  symbol: GPX
  source: bioentities_symbol
  hgnc_symbol: GPX8
  entrez: '493869'
- word: TGF-B1/Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: TGF-B1/Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: TGF-B1/Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: TGF-B1/Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: TNF-a,IL-6,etc.)
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: GPx,
  symbol: GPX
  source: bioentities_symbol
  hgnc_symbol: GPX3
  entrez: '2878'
- word: GPx,
  symbol: GPX
  source: bioentities_symbol
  hgnc_symbol: GPX4
  entrez: '2879'
- word: GPx,
  symbol: GPX
  source: bioentities_symbol
  hgnc_symbol: GPX5
  entrez: '2880'
- word: TGF-B1/Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: TGF-B1/Smad
  symbol: TGFB1
  source: hgnc_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
chemicals:
- word: ATP
  source: MESH
  identifier: D000255
- word: 8-OHDG
  source: MESH
  identifier: C090700
- word: MDA
  source: MESH
  identifier: D008315
- word: H
  source: MESH
  identifier: D006859
- word: EGCG
  source: MESH
  identifier: C045651
diseases:
- word: Mitochondrial dysfunction
  source: MESH
  identifier: D028361
---
